We Believe in Partnering

Overview

Together, We Can Reach Any Patient, Anywhere

At MediWound, our mission is to make NexoBrid accessible to burn patients worldwide. Through strategic partnerships and a growing global presence, we are expanding our reach and working to establish NexoBrid as the new standard of care in burn treatment, improving patients’ well-being and quality of life.

With a presence in over 40 countries, our commercialization efforts are powered by strong global collaborations. Success, we believe, begins with people. By combining MediWound’s innovative technology and dedicated team with our partners’ local market expertise and sales capabilities, we are well-positioned to elevate burn care standards on a global scale.

In addition, we are proud to announce a strategic collaboration with Mölnlycke Health Care, a global leader in wound care solutions. This partnership strengthens our plans for EscharEx and paves the way for substantial long-term value creation for our stakeholders while enhancing the quality of care for patients worldwide.

Strategic Partnerships

At MediWound, we believe that impactful partnerships drive meaningful progress. We are always seeking collaborations that amplify our reach and enhance patient care worldwide.
If you are interested in partnering with us, we invite you to connect. Together, we can create a brighter future for patients and healthcare providers alike.

Governmental Support

We are proud of our strategic collaboration in the U.S. with the Biomedical Advanced Research and Development Authority (BARDA), which has been instrumental in supporting the development and authorization of NexoBrid in the United States. This collaboration also includes the procurement of NexoBrid for the U.S. National Emergency Stockpile, ensuring readiness for burn care in emergency situations.

In addition, we are honored to partner with the U.S. Department of Defense (DoD) to advance NexoBrid as a non-surgical solution for treating burns under field conditions. Through the Medical Technology Enterprise Consortium (MTEC), the DoD has provided continued funding to further develop NexoBrid, addressing the unique needs of the U.S. Army for burn treatment in challenging environments.

Private Sector Partnerships

We are proud to collaborate with Vericel Corporation (Nasdaq: VCEL), a leader in advanced therapies for sports medicine and severe burn care. Through this partnership, Vericel markets and distributes NexoBrid across North America, including to over 140 burn centers in the United States. This collaboration ensures that patients have access to innovative, cutting-edge treatment for severe burns.

In addition, we have entered into a strategic collaboration with Mölnlycke Health Care, a globally recognized MedTech leader specializing in wound care and surgical solutions. This partnership is designed to advance our strategic plans for EscharEx, strengthening our position in the wound care market.

These alliances reflect our ongoing commitment to leveraging strategic partnerships to expand our reach, enhance our product offerings, and deliver transformative solutions to healthcare providers and patients worldwide.

$ 115M

$ 125M

$ 15M

$ 15M

Global Outreach

We recognize the vital role our distributors play in delivering NexoBrid to burn patients worldwide. By empowering our partners with the tools, knowledge, and support they need, we ensure that life-changing treatments reach those who need them most.

We employ a robust global strategy to commercialize NexoBrid, utilizing multiple sales channels to ensure broad availability and accessibility for burn patients. Our approach includes a dedicated European sales force, local sales representatives, and strategic partnerships with distributors across Europe and Asia. This integrated strategy enables us to deliver NexoBrid efficiently and effectively to patients worldwide.

40

COUNTRIES

MediWound Germany GmbH

Romania

Tel: +972 77 971 4100

MediWound Germany GmbH

Poland

Tel:

MediWound Germany GmbH

Italy

Tel: +972 77 971 4100244

MediWound Germany GmbH

United Kingdom

Tel: +972 77 971 4100

MediWound Germany GmbH

Spain

Tel: +972 77 971 4100

MediWound Germany GmbH

Norway

Tel: +972 77 971 4100

MediWound Germany GmbH

Germany, Austria, Switzerland

Tel: +972 77 971 4100

MediWound Germany GmbH

Belgium

Tel: +972 77 971 4100

MediWound Ltd.

Israel

Tel: +972 77 971 4100

Leander Healthcare B.V.

Netherlands, Luxemburg

Tel: +31 30 755 5380

Innova Medical Oy

Finland

Tel: +385 (0)50 4347412

Expomédica – Sociedade Exportadora E Importadora Material Médico, Lda

Portugal

Tel: +351 217957285

Avalon Pharmaceuticals S.A.

Panama

Tel: +57 1 6160255

Vericel Corporation

Mexico

Tel: +1 (617) 588-5555

Verciel Corporation

Canada

Tel: +1 (617) 588-5555

Vericel Corporation

U.S.A

Tel: +1 (617) 588-5555

Specialty Therapeutics PC

Bulgaria

Tel: + 30 213 02 33 913

Specialty Therapeutics PC

Greece, Cyprus, Malta

Tel: + 30 213 02 33 913

Genfa Medica S.A.

France

Tel: +41 22 710 05 50

Genfa Medica S.A.

Russia

Tel: + 41 22 710 05 50

Kaken Pharmaceutical Co., Ltd.

Japan

Tel: +81-3-5977-5046 Fax: +81-3-5977-5133

Learning Organization, LLC

Bangladesh

Tel: murali@learning-organized.com

Leraning Organization , LLC

Sri Lanka

Tel: murali@learning-organized.com

Balance Medical Pty. Ltd.

Australia

Tel: +61 1300 668 099

Learning Organized LLC

India

Tel: murali@learning-organized.com

BL&H Co., Ltd.

South Korea

Tel: +82-2-3282-4710 FAX: +82-2-3281-9081

Holy Stone Healthcare Co., Ltd.

The Republic of China (Taiwan)

Tel: +886-2-8797-5966 Fax: +886-2-2627-9729

Genfa Medica S.A.

Ukraine

Tel: +41 22 710 05 50

Ghassan Aboud Group FZE

United Arab Emirates

Tel: +971 4 881 6244

Asia Orphan ILAC SAN. TIC. A.S.

Turkey

Tel: +90 312 285 10 15

Genfa Medica S.A.

Latvia, Lithuania, Estonia

Tel: +41 22 710 05 50

Balance Medical Pty. Ltd.

New Zealand

Tel: + 61 1300 668 099

Avalon Pharmaceuticals S.A.

Colombia

Tel: +57 1 6160255

Avalon Pharmaceuticals S.A.

Chile

Tel: +57 1 6160255

Avalon Pharmaceuticals S.A.

Peru

Tel: +57 1 6160255

TUTEUR S.A.C.I.F.I.A.

Argentina

Tel: +54 11 5787 2222

Avalon Pharmaceuticals S.A.

Ecuador

Tel: +57 1 6160255

  • Direct distribution
  • Sales representative
  • Distributors

Global Partnerships